Home › Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion
 

Keywords :   


Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

2015-03-30 18:34:10| Biotech - Topix.net

Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system. Teva, the world's largest maker of generic drugs, will offer $101 per share in cash, representing a premium of 42.4 percent to Auspex's Friday closing price, the companies said on Monday.

Tags: buy drug developer billion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »